Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1297 to 1302 of 1302 entries
Sorted by: Best Match Show Resources per page
Evaluation of auto-segmentation accuracy of cloud-based artificial intelligence and atlas-based models.

Radiation oncology (London, England)

Urago Y, Okamoto H, Kaneda T, Murakami N, Kashihara T, Takemori M, Nakayama H, Iijima K, Chiba T, Kuwahara J, Katsuta S, Nakamura S, Chang W, Saitoh H, Igaki H.
PMID: 34503533
Radiat Oncol. 2021 Sep 09;16(1):175. doi: 10.1186/s13014-021-01896-1.

BACKGROUND: Contour delineation, a crucial process in radiation oncology, is time-consuming and inaccurate due to inter-observer variation has been a critical issue in this process. An atlas-based automatic segmentation was developed to improve the delineation efficiency and reduce inter-observer...

Cite
Urago Y, Okamoto H, Kaneda T, et al. Evaluation of auto-segmentation accuracy of cloud-based artificial intelligence and atlas-based models. Radiat Oncol. 2021;16(1):175doi: 10.1186/s13014-021-01896-1.
Urago, Y., Okamoto, H., Kaneda, T., Murakami, N., Kashihara, T., Takemori, M., Nakayama, H., Iijima, K., Chiba, T., Kuwahara, J., Katsuta, S., Nakamura, S., Chang, W., Saitoh, H., & Igaki, H. (2021). Evaluation of auto-segmentation accuracy of cloud-based artificial intelligence and atlas-based models. Radiation oncology (London, England), 16(1), 175. https://doi.org/10.1186/s13014-021-01896-1
Urago, Yuka, et al. "Evaluation of auto-segmentation accuracy of cloud-based artificial intelligence and atlas-based models." Radiation oncology (London, England) vol. 16,1 (2021): 175. doi: https://doi.org/10.1186/s13014-021-01896-1
Urago Y, Okamoto H, Kaneda T, Murakami N, Kashihara T, Takemori M, Nakayama H, Iijima K, Chiba T, Kuwahara J, Katsuta S, Nakamura S, Chang W, Saitoh H, Igaki H. Evaluation of auto-segmentation accuracy of cloud-based artificial intelligence and atlas-based models. Radiat Oncol. 2021 Sep 09;16(1):175. doi: 10.1186/s13014-021-01896-1. PMID: 34503533; PMCID: PMC8427857.
Copy Download .nbib Format: NLM
Dopaminergic restoration of prefrontal cortico-putaminal network in gene therapy for aromatic l-amino acid decarboxylase deficiency.

Brain communications

Onuki Y, Ono S, Nakajima T, Kojima K, Taga N, Ikeda T, Kuwajima M, Kurokawa Y, Kato M, Kawai K, Osaka H, Sato T, Muramatsu SI, Yamagata T.
PMID: 34423296
Brain Commun. 2021 Apr 15;3(3):fcab078. doi: 10.1093/braincomms/fcab078. eCollection 2021.

Aromatic l-amino acid decarboxylase (AADC) is an essential dopamine-synthesizing enzyme. In children with AADC deficiency, the gene delivery of AADC into the putamen, which functionally interacts with cortical regions, was found to improve motor function and ameliorate dystonia. However,...

Cite
Onuki Y, Ono S, Nakajima T, et al. Dopaminergic restoration of prefrontal cortico-putaminal network in gene therapy for aromatic l-amino acid decarboxylase deficiency. Brain Commun. 2021;3(3):fcab078doi: 10.1093/braincomms/fcab078.
Onuki, Y., Ono, S., Nakajima, T., Kojima, K., Taga, N., Ikeda, T., Kuwajima, M., Kurokawa, Y., Kato, M., Kawai, K., Osaka, H., Sato, T., Muramatsu, S. I., & Yamagata, T. (2021). Dopaminergic restoration of prefrontal cortico-putaminal network in gene therapy for aromatic l-amino acid decarboxylase deficiency. Brain communications, 3(3), fcab078. https://doi.org/10.1093/braincomms/fcab078
Onuki, Yoshiyuki, et al. "Dopaminergic restoration of prefrontal cortico-putaminal network in gene therapy for aromatic l-amino acid decarboxylase deficiency." Brain communications vol. 3,3 (2021): fcab078. doi: https://doi.org/10.1093/braincomms/fcab078
Onuki Y, Ono S, Nakajima T, Kojima K, Taga N, Ikeda T, Kuwajima M, Kurokawa Y, Kato M, Kawai K, Osaka H, Sato T, Muramatsu SI, Yamagata T. Dopaminergic restoration of prefrontal cortico-putaminal network in gene therapy for aromatic l-amino acid decarboxylase deficiency. Brain Commun. 2021 Apr 15;3(3):fcab078. doi: 10.1093/braincomms/fcab078. eCollection 2021. PMID: 34423296; PMCID: PMC8374966.
Copy Download .nbib Format: NLM
Three tumor markers for improved efficacy in the management of patients with malignant pleural mesothelioma.

Journal of thoracic disease

Nakamura A, Takuwa T, Hashimoto M, Kuroda A, Nakamichi T, Matsumoto S, Kondo N, Kijima T, Hasegawa S.
PMID: 33282372
J Thorac Dis. 2020 Nov;12(11):6712-6721. doi: 10.21037/jtd-20-1910.

BACKGROUND: Evaluation of tumor markers may facilitate follow-up of malignant pleural mesothelioma (MPM). We aimed was to evaluate the value of tumor markers for monitoring and predicting recurrence in patients with MPM.METHODS: In total, 152 patients who underwent curative-intent...

Cite
Nakamura A, Takuwa T, Hashimoto M, et al. Three tumor markers for improved efficacy in the management of patients with malignant pleural mesothelioma. J Thorac Dis. 2020;12(11):6712-6721doi: 10.21037/jtd-20-1910.
Nakamura, A., Takuwa, T., Hashimoto, M., Kuroda, A., Nakamichi, T., Matsumoto, S., Kondo, N., Kijima, T., & Hasegawa, S. (2020). Three tumor markers for improved efficacy in the management of patients with malignant pleural mesothelioma. Journal of thoracic disease, 12(11), 6712-6721. https://doi.org/10.21037/jtd-20-1910
Nakamura, Akifumi, et al. "Three tumor markers for improved efficacy in the management of patients with malignant pleural mesothelioma." Journal of thoracic disease vol. 12,11 (2020): 6712-6721. doi: https://doi.org/10.21037/jtd-20-1910
Nakamura A, Takuwa T, Hashimoto M, Kuroda A, Nakamichi T, Matsumoto S, Kondo N, Kijima T, Hasegawa S. Three tumor markers for improved efficacy in the management of patients with malignant pleural mesothelioma. J Thorac Dis. 2020 Nov;12(11):6712-6721. doi: 10.21037/jtd-20-1910. PMID: 33282372; PMCID: PMC7711396.
Copy Download .nbib Format: NLM
[The new curriculum at St. Luke's College of Nursing (1995 edition)].

Sei Roka Kango Daigaku kiyo

Hishinuma M, Koyama M, Kojima M, Tokiwa K, Kaharu C, Miyasaka Y, Sukegawa H, Kimura T, Ito K, Kikutu F, Iwai I, Komatu H, Horiruchi S, Oikawa I, Nakayama Y, Iida S, Arai C, Hayama Y, Oota K, Noji A.
PMID: 9479194
Seiroka Kango Daigaku Kiyo. 1996;22:113-21.

No abstract available.

Cite
Hishinuma M, Koyama M, Kojima M, et al. [The new curriculum at St. Luke's College of Nursing (1995 edition)]. Seiroka Kango Daigaku Kiyo. 1996;22:113-21
Hishinuma, M., Koyama, M., Kojima, M., Tokiwa, K., Kaharu, C., Miyasaka, Y., Sukegawa, H., Kimura, T., Ito, K., Kikutu, F., Iwai, I., Komatu, H., Horiruchi, S., Oikawa, I., Nakayama, Y., Iida, S., Arai, C., Hayama, Y., Oota, K., & Noji, A. (1996). [The new curriculum at St. Luke's College of Nursing (1995 edition)]. Sei Roka Kango Daigaku kiyo, 22113-21.
Hishinuma, M, et al. "[The new curriculum at St. Luke's College of Nursing (1995 edition)]." Sei Roka Kango Daigaku kiyo vol. 22 (1996): 113-21.
Hishinuma M, Koyama M, Kojima M, Tokiwa K, Kaharu C, Miyasaka Y, Sukegawa H, Kimura T, Ito K, Kikutu F, Iwai I, Komatu H, Horiruchi S, Oikawa I, Nakayama Y, Iida S, Arai C, Hayama Y, Oota K, Noji A. [The new curriculum at St. Luke's College of Nursing (1995 edition)]. Seiroka Kango Daigaku Kiyo. 1996;22:113-21. Japanese. PMID: 9479194.
Copy Download .nbib Format: NLM
Sevoflurane-based enhancement of phase-amplitude coupling and localization of the epileptogenic zone.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology

Wada K, Sonoda M, Firestone E, Sakakura K, Kuroda N, Takayama Y, Iijima K, Iwasaki M, Mihara T, Goto T, Asano E, Miyazaki T.
PMID: 34922194
Clin Neurophysiol. 2021 Dec 01;134:1-8. doi: 10.1016/j.clinph.2021.11.004. Epub 2021 Dec 01.

OBJECTIVE: Phase-amplitude coupling between high-frequency (≥150 Hz) and delta (3-4 Hz) oscillations - modulation index (MI) - is a promising, objective biomarker of epileptogenicity. We determined whether sevoflurane anesthesia preferentially enhances this metric within the epileptogenic zone.METHODS: This is...

Cite
Wada K, Sonoda M, Firestone E, et al. Sevoflurane-based enhancement of phase-amplitude coupling and localization of the epileptogenic zone. Clin Neurophysiol. 2021;134:1-8doi: 10.1016/j.clinph.2021.11.004.
Wada, K., Sonoda, M., Firestone, E., Sakakura, K., Kuroda, N., Takayama, Y., Iijima, K., Iwasaki, M., Mihara, T., Goto, T., Asano, E., & Miyazaki, T. (2021). Sevoflurane-based enhancement of phase-amplitude coupling and localization of the epileptogenic zone. Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, 1341-8. https://doi.org/10.1016/j.clinph.2021.11.004
Wada, Keiko, et al. "Sevoflurane-based enhancement of phase-amplitude coupling and localization of the epileptogenic zone." Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology vol. 134 (2021): 1-8. doi: https://doi.org/10.1016/j.clinph.2021.11.004
Wada K, Sonoda M, Firestone E, Sakakura K, Kuroda N, Takayama Y, Iijima K, Iwasaki M, Mihara T, Goto T, Asano E, Miyazaki T. Sevoflurane-based enhancement of phase-amplitude coupling and localization of the epileptogenic zone. Clin Neurophysiol. 2021 Dec 01;134:1-8. doi: 10.1016/j.clinph.2021.11.004. Epub 2021 Dec 01. PMID: 34922194.
Copy Download .nbib Format: NLM
Genotype-Phenotype Correlation in .

Kidney international reports

Nagano C, Takaoka Y, Kamei K, Hamada R, Ichikawa D, Tanaka K, Aoto Y, Ishiko S, Rossanti R, Sakakibara N, Okada E, Horinouchi T, Yamamura T, Tsuji Y, Noguchi Y, Ishimori S, Nagase H, Ninchoji T, Iijima K, Nozu K.
PMID: 34386660
Kidney Int Rep. 2021 May 19;6(8):2114-2121. doi: 10.1016/j.ekir.2021.05.009. eCollection 2021 Aug.

METHODS: We conducted a systematic review of 174 cases with RESULTS: The median age of developing ESKD was 1.17 years. A comparative study was conducted among three CONCLUSION: Not only the DNA-binding site but also C2H2 zinc finger structure...

Cite
Nagano C, Takaoka Y, Kamei K, et al. Genotype-Phenotype Correlation in . Kidney Int Rep. 2021;6(8):2114-2121doi: 10.1016/j.ekir.2021.05.009.
Nagano, C., Takaoka, Y., Kamei, K., Hamada, R., Ichikawa, D., Tanaka, K., Aoto, Y., Ishiko, S., Rossanti, R., Sakakibara, N., Okada, E., Horinouchi, T., Yamamura, T., Tsuji, Y., Noguchi, Y., Ishimori, S., Nagase, H., Ninchoji, T., Iijima, K., & Nozu, K. (2021). Genotype-Phenotype Correlation in . Kidney international reports, 6(8), 2114-2121. https://doi.org/10.1016/j.ekir.2021.05.009
Nagano, China, et al. "Genotype-Phenotype Correlation in ." Kidney international reports vol. 6,8 (2021): 2114-2121. doi: https://doi.org/10.1016/j.ekir.2021.05.009
Nagano C, Takaoka Y, Kamei K, Hamada R, Ichikawa D, Tanaka K, Aoto Y, Ishiko S, Rossanti R, Sakakibara N, Okada E, Horinouchi T, Yamamura T, Tsuji Y, Noguchi Y, Ishimori S, Nagase H, Ninchoji T, Iijima K, Nozu K. Genotype-Phenotype Correlation in . Kidney Int Rep. 2021 May 19;6(8):2114-2121. doi: 10.1016/j.ekir.2021.05.009. eCollection 2021 Aug. PMID: 34386660; PMCID: PMC8343804.
Copy Download .nbib Format: NLM
Showing 1297 to 1302 of 1302 entries